Viewing Study NCT06718894


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2025-12-26 @ 1:53 AM
Study NCT ID: NCT06718894
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-12-05
First Post: 2024-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Multitarget Strategy for Primary Podocytopathies
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Organization:

Study Overview

Official Title: Multitarget Strategy for Primary Podocytopathies
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PODO-TARGET
Brief Summary: The goal of this clinical trial is to verify whether a cell culture system can be used to evaluate the presence of a factor capable of causing proteinuria in the serum of patients with primary podocytopathies. This system will also be used to evaluate the in vitro efficacy of a combined therapy for the treatment of this disorder.

Researchers will compare samples from patients with primary podocytopathies with those obtained from healthy subjects and patients with other renal disorders.

Participants will be asked to visit the clinic at regular intervals for up to 36 months, and to provide blood and urine samples (and a sample of the discarded plasmapheresis effluent in case the procedure is performed).
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: